http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-49084-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4843b35261c43e68ec3d41a87e363ed0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04
filingDate 2000-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e24af5b7f8844bfefdd2033a5ececd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc35c4de899672d99a916b918b2e83dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d80686460590c46c766ef4504ddc90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e7e0ceaa51943b4c632659d9a106a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fceedb1cd8b2e3fc5f158cbfba4cf406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a480aae196005613480835abbc0f2ef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab1f27b70da35d31e1bde4ac34fd5e1d
publicationDate 2002-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-49084-C2
titleOfInvention MEANS FOR TREATMENT OF DISORDERS OF SEXUAL FUNCTION IN MEN OF "YOHIMBE-GENESIS"
abstract The invention relates to medicine and the pharmaceutical industry, in particular, to the creation, production and use of agents for treating sexual dysfunction in men. The composition of the product in capsule form includes the following ingredients (in wt.%): Yohimbine hydrochloride (1,000-4,500), arginine hydrochloride (15,300-80,000), sodium selenite (0,008-0,060), zinc oxide (3,000-14,000) , nicotinic acid or niacin (1,400-10,000), calcium pantothenate (2,000-28,000), ascorbic acid (the rest).
priorityDate 2000-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448013983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24934

Total number of triples: 34.